Proteins Suggest a Path to Reduce Drug Resistance in a Form of Cancer

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed, thanks to a study o

Related Keywords

Richland ,Oregon ,United States ,American ,Tao Liu ,Paul Daisy Soros ,Chelsea Hutchinson ,Kevin Watanabe Smith ,Jeff Tyner ,Kanupriya Agarwal ,Jason Mcdermott ,Joshua Hansen ,Brian Druker ,Karin Rodland ,Marina Gritsenko ,Cristina Tognon ,Sunil Joshi ,Michael Nestor ,Karl Weitz ,Sara Gosline ,Paul Piehowski ,Elie Traer ,James Pino ,Blood Institute ,Knight Cancer Institute ,School Of Medicine ,Druker Laboratory ,Pacific Northwest Biomedical Innovation Co ,Alex Lemonade Stand Foundation ,Oregon Health Science University ,Department Of Energy Pacific Northwest National Laboratory ,Research Program ,National Cancer Institute ,National Heart ,Evansmds Foundation ,Scholar Foundation ,American Cancer Society ,Cell Reports Medicine ,Pacific Northwest National Laboratory ,Oregon Health ,Knight Cancer ,Annual Reviews ,Camilo Posso ,Jamie Moon ,Chelsea Hutchinson Bunch ,Nicola Long ,Cancer Clinical Proteomics Research ,Daisy Soros Fellowship ,Lemonade Stand ,Newswise ,Cute Myeloid Leukemia Aml Proteogenomics Omics Drug Resistance ,All Journal News ,Dancer ,Drug Resistance ,Cell Journal ,Doe Science News Source ,